Lupin shares saw an uptick after Jefferies raised its target price and reiterated a “Buy” rating post-strong Q2 results. The US business hit a multi-year high with $315 million in sales, supported by new launches and robust margins, prompting upward revisions to FY26–FY27 earnings and growth outlook.